Insta
J&J's Single-Shot COVID-19 Vaccine Becomes Fifth Jab To Get Approval For Emergency Use In India
(A picture of vaccine vials from Johnson and Johnson)
United States-based pharmaceutical giant Johnson and Johnson (J&J) has received the emergency use approval for its Covid-19 vaccine in India, informed Union Health Minister Mansukh Mandaviya on Saturday (6 August).
J&J's Covid-19 vaccine is the fifth jab to be approved for emergency-use in India.
"India expands its vaccine basket! Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines. This will further boost our nation's collective fight against COVID-19," Mandaviya said in a tweet.
In a statement issued on Friday (6 August), the US pharma major said that it had submitted its emergency use approval application to the Indian drug regulator on Thursday (5 August).
J&J's vaccine developed by Janssen Pharmaceutical Companies of Johnson & Johnson comprises one shot and reportedly found to have 85.4 per cent efficacy against severe disease and 93.1 per cent against hospitalisation.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest
